Announcement of the Resolutions of the First Extraordinary Shareholders Meeting of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. in 2026

Securities code: 603567 Securities abbreviation: Zhenbaodao Announcement number: Lin 2026-034 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

Announcement of Resolutions of the First Extraordinary Shareholders Meeting in 2026

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Important content reminder:

 Is there any veto resolution at this meeting: None

1. Meeting convening and attendance

(1) Time of the shareholders’ meeting: April 20, 2026

(2) The location of the shareholders’ meeting: No. 8, Yantai 1st Road, Pingfang Development Zone, Harbin

(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:

1. Number of shareholders and proxies attending the meeting 287

2. Total number of shares with voting rights held by shareholders attending the meeting (shares) 473,912,419

3. The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares.

50.3702 Proportion of total number of copies (%)

(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc.

This meeting was convened by the company's board of directors and chaired by Mr. Yan Jiujiang, the company's chairman. This meeting voted on the matters listed in the notice of shareholders’ meeting through a combination of on-site and online voting. The voting method complied with the provisions of the Company Law and the Articles of Association.

(5) Attendance of company directors and board secretary

1. The company has 5 current directors and 5 non-voting directors;

2. The secretary of the board of directors and senior managers attended this meeting.

2. Proposal review status

(1) Non-cumulative voting proposals

1. Proposal name: Proposal on canceling the company’s repurchase of treasury shares in the special securities account

Review result: Passed

Voting status:

Agree Disagree Abstain

Type of shareholder Number of votes Proportion Number of votes Proportion Number of votes Proportion (%) (%) (%) A shares 473,228,019 99.8556 536,400 0.1132 148,000 0.0312

2. Proposal title: Proposal on formulating the "Remuneration and Performance Appraisal Management System for Directors and Senior Management of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd."

Review result: Passed

Voting status:

Agree Disagree Abstain

Type of shareholder Number of votes Proportion Number of votes Proportion Number of votes Proportion (%) (%) (%) A shares 471,935,219 99.5828 1,864,600 0.3934 112,600 0.0238

(2) When major matters are involved, the voting status of shareholders below 5%

Motion Name of motion Agree Oppose Abstention number Number of votes Proportion of votes Proportion of votes Proportion (%) (%) (%) Regarding the formulation of "Heilongjiang

Zhenbaodao Pharmaceutical Co., Ltd.

Limited Company Directors and

1 6,519,919 76.7309 1,864,600 21.9439 112,600 1.3252 Senior management salary

Compensation and performance appraisal management

Proposal on the Management System

(3) Explanation of relevant circumstances regarding voting on motions

None

3. Lawyer’s testimony

1. The law firm witnessing this shareholder meeting: Beijing Lantai Law Firm

Lawyers: Zhang Buyong, Wang Ting

2. Lawyer’s concluding comments:

The convening and holding procedures of this shareholders' meeting of the company comply with the provisions of the "Company Law" and other laws, administrative regulations, "Rules for Shareholders' Meetings of Listed Companies" and "Articles of Association"; the qualifications of the convener of this shareholders' meeting and the qualifications of attendees are legal and valid; the voting procedures and voting results of this shareholders' meeting are legal and valid.

Announcement is hereby made.

Board of Directors of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

April 21, 2026

 Online announcement documents

A certified legal opinion signed and stamped by the director of the law firm